The marijuana industry has become quite dominated by companies that are working out of either the U.S. or Canadian cannabis space. Many companies have decided that the best mode of work is to put products forth in both markets which has become quite common. These companies, which are mostly the growers of the substance, have become some of the key players in the entirety of the industry. With so much opportunity coming out of the North American cannabis industry, it seems as though there are no signs of slowing down in sight.

 Several Canada-based marijuana growers could be impacted by a build-up of un-sellable “sub-par quality” cannabis, as well as a slower rollout of retail sales, one of Wall Street’s top marijuana analysts said Monday.

One reason marijuana quality can be poor is high level of moisture content. That’s why we’re highlighting THC Therapeutics, Inc. (THCT). The company’s dHydronator can reduce moisture content of cannabis to 10% in only 10-14 hours. Companies with products like THCT could help solve the industry’s quality problem.

Of the 46 marijuana stocks in the North American Marijuana Index, I guess that a handful of them are currently making money. That’s the extent of it.

From that perspective, it’s a very daunting task picking the winners from the losers, because they all tell a good tale. But when it comes to separating the wheat from the chaff, the stocks to buy and sell aren’t nearly as easy to uncover.

Cannabis e-commerce platforms, both medical and recreational, are becoming increasingly important as Canada's legal marijuana market matures.

However, given that only two of Canada's ten provinces—Manitoba and Saskatchewan—currently allow private marijuana retailers to sell cannabis online, online medical marijuana stores have continued to reign supreme in Canada's online cannabis market.

To get a better understanding of how Canada's online marijuana market is developing, we take a closer look at some of Canada’s most promising medical and recreational cannabis e-commerce platforms.

With some analysts calling for a potential recession, they are predicting the cannabis industry will be one of the top industries capable of delivering a healthy return on investment. Spending on legal cannabis in the U.S. is expected to increase from $12.9 billion in 2019 to $20.4 billion in 2022, according to New Frontier Data.

The future of Canada’s cannabis industry may not be as rosy as once believed after one research firm cut their estimates for the outlook on the country’s burgeoning pot market.

Cannabis industry research firm BDS Analytics said Canada’s pot market is expected to grow to US$5.2 billion by 2024 up from US$569 million last year. While that growth reflects a relatively strong compound annual growth rate of about 44 per cent over the next five years, it also is shy of BDS’s previous January forecast of the Canadian market of US$5.9 billion by 2022.

We have gushed frequently enough over OrganiGram Holdings Inc (OTCMKTS:OGRMF) shares to solidify our track record there. For its part, the stock has done plenty to vindicate that perspective, consistently leading the cannabis space on the upside over the past few months, powering as much as 120% higher in that time, and banging once again on new all-time highs. To further flesh out the story, the company just announced the recent appointment of strategy and operations consultant James Cavanagh as the Company’s Chief of Staff.

Canada-based Village Farms International (NASDAQ:VFF) is one of the largest and longest-operating greenhouse growers in North America, with 30 years of experience growing vegetables such as tomatoes, cucumbers, and peppers. The company operates 240 acres, or 10.5 million square feet, of huge greenhouses, with roughly half in British Columbia and half in Texas. 

The resurgence in the cannabis sector to start 2019 is largely responsible for dragging the Canadian equity market out of the December doldrums. Investors are now wondering whether pot stocks will continue to lead the way through the end of 2019 and beyond.

So far, 2019 is turning out to be a very good year for many marijuana stocks. But not for all of them. Tilray (NASDAQ:TLRY), for example, is performing much worse than most of its peers, with its share price slipping nearly 16% year to date. However, Tilray ranked as the top-performing Canadian marijuana stock of 2018. The company has tremendous opportunities for growth in the future. If you’re looking to buy Tilray while it’s down, though, here are five things you should know first.